TRIA drops price
This article was originally published in The Rose Sheet
Executive Summary
TRIA Laser Hair Removal System is more affordable with a new $495 price tag, reflecting a $100 drop. "As a category leader, TRIA Beauty is committed to providing the best products at the best price possible," says Kevin Appelbaum, CEO of TRIA Beauty. "As global growth has driven costs down, we are able to pass the savings to the consumer to expand access to our products." Pricing is a critical component in the home-use aesthetic device segment (1"The Rose Sheet" March 30, 2009). The TRIA Laser uses a diode laser, the same technology used in professional laser hair removal systems. "It is the first and only FDA-cleared hair removal system that's been clinically proven to deliver permanent results at-home," according to the company, which is expanding sales of the product and the TRIA Skin Clarifying System ($295) to Bloomingdales, Neiman Marcus and Bergdorf Goodman. TRIA products also are available at TRIABeauty.com and Nordstrom stores
You may also be interested in...
Watch Out, Razors, Here Come Lasers; Skinovations’ Silk’n Rolling Out OTC
With the OTC launch of Home Skinovations' Silk'n SensEpil device this spring - and with TRIA Beauty expanding distribution of its system - conventional hair-removal products could begin losing favor with women seduced by the idea of laser hair removal in the home
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.